Surrey Heartlands

Joint Formulary & PAD

Atropine sulfate - Uveitis

You are here : Home > Formulary Search > Atropine sulfate - Uveitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Eye drops
  • Eye drops (preservative free
  • unit dose)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :

Documentation

Evidence Review
Atropine colour change application Sep-18

PAD Profile

ChemicalSubstance :
Atropine sulfate
Indication :
Uveitis
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Atropine sulfate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Uveitis.

Committee Recommendations (1)

05 Sep 18 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network recommends the use of Atropine for the treatment of licensed hospital indications ( including Iritis and Uveitis)

Atropine will be considered to be RED on the traffic light system.

New patients:

·         Should be initiated on Atropine 1% minims® by their consultant ophthalmologist 

·         Patients with manual dexterity issues can be initiated on Atropine 1% eye drop (bottles)

Switching patients from Atropine 1% eye drops (bottles):

Patients currently using Atropine 1% eye drops for licensed indications who do not have manual dexterity issues, should be switched to Atropine 1% minims® at their next medication review.